Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gold compounds in rheumatic diseases--2.

M D Smith, P M Brooks

    The Medical Journal of Australia
    |January 21, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Gold therapy remains crucial for rheumatic diseases, with continuous intramuscular injections preferred. Oral gold may offer new options, but strict monitoring is essential to manage high toxicity and prevent severe side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quantification of the cell infiltrate in synovial tissue by digital image analysis.

    Rheumatology (Oxford, England)·2000
    Same author

    Sildenafil citrate (VIAGRA): a novel oral treatment for erectile dysfunction caused by traumatic spinal cord injury.

    International journal of clinical practice. Supplement·2000
    Same author

    Sildenafil citrate (VIAGRA): analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction. Multicentre Study Group.

    International journal of clinical practice. Supplement·2000
    Same author

    Sildenafil citrate (VIAGRA), an oral treatment for erectile function: 1-year, open-label, extension studies. Multicentre Study Group.

    International journal of clinical practice. Supplement·2000
    Same author

    Treatment of acute liver failure: hybrid liver support. A critical overview.

    Langenbeck's archives of surgery·2000
    Same author

    Rheumatoid arthritis, disability and the workplace.

    Bailliere's best practice & research. Clinical rheumatology·2000
    Same journal

    Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

    The Medical journal of Australia·2026
    Same journal

    Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

    The Medical journal of Australia·2026
    Same journal

    Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

    The Medical journal of Australia·2026
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Pharmacology
    • Toxicology

    Background:

    • Gold compounds are established treatments for rheumatic diseases.
    • Continuous intramuscular administration is currently recommended over intermittent therapy.
    • High rates of treatment termination due to side effects or lack of efficacy persist.

    Purpose of the Study:

    • To review the current role and challenges of gold therapy in rheumatic diseases.
    • To discuss the potential of oral gold preparations.
    • To emphasize the importance of monitoring for gold compound toxicity.

    Main Methods:

    • Review of existing literature on gold therapy in rheumatology.
    • Discussion of clinical recommendations for administration and monitoring.

    Related Experiment Videos

  • Analysis of toxicity profiles and management strategies.

    • Main Results:

    • Continuous intramuscular gold therapy is favored, but long-term efficacy and side effects remain concerns.
    • Oral gold preparations present a potential alternative approach.
    • Toxicity of gold compounds necessitates rigorous monitoring, including regular blood tests for platelet and neutrophil counts.

    Conclusions:

    • Gold therapy continues to be significant in managing rheumatic conditions.
    • Careful patient monitoring is paramount to mitigate the high toxicity associated with gold compounds.
    • Early identification of adverse effects is key to preventing severe complications.